';
Mental Health

Act 66 of 2023 requires the Pennsylvania Department of Drug and Alcohol Programs (DDAP) to annually report to the Senate Health and Human Services Committee and House Human Services Committee, among other information, barriers to entry into the SUD workforce. To help fulfill that requirement, DDAP is surveying providers to get their input on this topic.

In addition to this reporting requirement, Act 66 of 2023 also put in place several regulatory flexibilities about which providers are also being asked through this survey, though DDAP is not legislatively mandated to report on the use of these flexibilities.

The deadline to submit the survey is 5:00 pm Sunday, December 21, 2025.

Tuesday, January 6, 2026
1:00 pm – 2:00 pm ET; 12:00 pm – 1:00 pm CT;
11:00 am – 12:00 pm MT; 10:00 am – 11:00 am PT
Register Here

Please join us as the IPRC hosts special guest Terry Carolan from CARF International, who will share the new Disorders of Consciousness Program Standards.

Presenter Bio:

Terrence Carolan
Terrence Carolan, Managing Director of the Medical Rehabilitation and Aging Services accreditation areas at the Commission on Accreditation of Rehabilitation Facilities (CARF), has more than 20 years of experience as a provider, administrator, and educator in the human services field. Terry joined CARF after working in clinical and administrative leadership positions within Select Medical’s Inpatient Rehabilitation Division and the Kessler Institute for Rehabilitation since 2001. Terry was a CARF surveyor for 10 years and holds a degree in physical therapy from Simmons College in Boston. He also recently completed his master’s degree in business administration from the University of Wisconsin-Eau Claire.

Objectives: At the end of this session, the learner will:

  • Describe recent research and guidance on the treatment of individuals with Disorders of Consciousness (DoC);
  • Discuss how CARF International has responded to guidance from the field to create Disorders of Consciousness Program Standards; and
  • Analyze how new DoC accreditation and recent research will enhance access to rehabilitation for children with DoC in the future.

Audience: This webinar is intended for all interested members of the rehabilitation team; attendees do not need to be CARF certified in order to attend.

Level: Beginner-Intermediate

Certificate of Attendance: Certificates of attendance are available for all attendees. No CEs are available for this course.

Message from the Office of Mental Health and Substance Abuse Services (OMHSAS):

The Pennsylvania Department of Human Services’ (DHS) Office of Mental Health and Substance Abuse Services (OMHSAS) is issuing the bulletin OMHSAS-25-05 “Behavioral Health Clinic Services Provided Outside of the Clinic,” effective November 12, 2025, following changes to Federal Regulation 42 CFR 440.90(d).

OMHSAS 25-05 announces an amendment to Pennsylvania’s Medicaid State Plan which allows all behavioral health clinics that are enrolled in the Medical Assistance (MA) Program, who deliver services through the fee-for-service and managed care systems, to provide clinically appropriate services outside of the clinic. Behavioral health clinics include psychiatric outpatient clinics, outpatient drug and alcohol clinics, and methadone maintenance clinics.

Furthermore, OMHSAS-25-05 also announces the abrogation of 55 Pa Code §§ 1153.14(6) (relating to noncovered services) and 55 Pa. Code 1223.14(11) (relating to noncovered services) by Act 46 of 2025.

The guidance in OMHSAS-25-05 is separate from any “telehealth only” licensure and guidance that may be in place. The changes discussed in this bulletin also do not apply to the existing Mobile Mental Health Telehealth (MMHT) services.

Questions and comments can be directed to OMHSAS via email. RCPA members can also contact RCPA COO and MH Policy Director Jim Sharp with any questions.

RCPA is excited to host a membership benefits webinar on Wednesday, January 14, 2026, at 1:00 pm, as an opportunity for members to orient themselves with all that RCPA membership includes. This is not just for new and future members. For current members, there may be benefits associated with our membership that you may not be aware of, including targeted meetings and groups that are held throughout the year.

Registration is required; please register here to attend the webinar. Attendees will have the opportunity to:

  • Virtually meet the dedicated RCPA Policy Staff and RCPA lobbyists;
  • Discuss the 2026 Legislative and Administrative priorities;
  • Preview RCPA divisional committee and subcommittee meetings and what they offer;
  • View the RCPA member-only website;
  • Review exclusive yearly educational and networking events; and
  • Understand the value of the National Council and ANCOR memberships included with RCPA membership.

Visit the RCPA member benefits web page for more information, or contact Tieanna Lloyd for benefit details.

TrueNorth Wellness Services (TNWS) and its Board of Directors are pleased to announce the appointment of Steven (Steve) J. Schedler, LCSW, CAADC, CCS as its new Chief Executive Officer (CEO), effective January 5, 2026.

With a strong record of leadership in the mental health field, Steve brings a renewed vision for expanding and strengthening our commitment to providing compassionate, high quality behavioral health and wellness services to the communities we serve. Throughout his career, he has demonstrated a deep commitment to expanding access to high quality behavioral health and wellness services, values that align closely with TrueNorth’s intended mission.

We are confident that Steve’s vision and leadership will help TNWS continue to grow and serve our communities with excellence.

Steve replaces Chuck Smith, who has served as the TNWS interim CEO since April 2025.

Professional Background
Steve Schedler comes to TNWS with over 20 years’ experience in the behavioral health field. Since 2020, he has served as the Executive Director of Samaritan Center, where he oversaw clinical and administrative operations.  Prior to that, he served as Executive Director of Naaman Center, a role he led a comprehensive array of addiction treatment services.

These combined leadership experiences, along his roles as a therapist, have equipped Steve with a deep understanding of behavioral health systems, as well as a proven ability to guide diverse teams, implement strategic initiatives and support sustainable service delivery.

Education
Steve holds a Bachelor of Science degree in Psychology from The Pennsylvania State University, a Masters of Social Work degree from Temple University, along with several professional designations.

Personal Background
A native of Franklin County (Mont Alto), PA and a Waynesboro High School graduate, Steve currently lives in Hershey, PA with his wife Amy and two children, Levi and Maddie.

As we begin this new chapter, we are confident that Steve’s leadership and experience will guide TNWS toward continues growth impact. We welcome Steve to TNWS and look forward to the positive energy and direction he will deliver to our team.

The Office of Developmental Programs (ODP) has shared this important announcement from the U. S. Food and Drug Administration (FDA).

The FDA is aware that Abbott Diabetes Care has sent all affected customers, distributors, and health care providers a letter regarding an issue with certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors providing incorrect low glucose readings. If undetected, incorrect low glucose readings over an extended period may lead to wrong treatment decisions for people living with diabetes, such as excessive carbohydrate intake or skipping or delaying insulin doses. These decisions may pose serious health risks, including potential injury or death, or other less serious complications.

As of November 14, 2025, Abbott has reported 736 serious injuries and seven deaths associated with this issue.

Affected Product

  • FreeStyle Libre 3 Sensor
    • Model Numbers: 72081-01, 72080-01
    • Unique Device Identifiers (UDI-DI): 00357599818005, 00357599819002
  • FreeStyle Libre 3 Plus Sensor
    • Model Numbers: 78768-01, 78769-01
    • Unique Device Identifiers (UDI-DI): 00357599844011, 00357599843014
  • Download the full list of affected lots

What to Do:

Patients should verify if their sensors are impacted and immediately discontinue use and dispose of the affected sensor(s).

On November 24, 2025, Abbott Diabetes Care sent all affected customers a letter recommending the following actions:

  • For Patients:
    • Determine if your current or unused sensor(s) are affected by visiting FreeStyle Check and selecting “CONFIRM SENSOR SERIAL NUMBER.” You will need to locate your sensor serial number to determine if your sensor is affected.
      • If you are wearing a FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensor, you can find the serial number in the app or reader. The serial number can also be found on the label on the bottom of the sensor applicator or carton. (If you are using a sensor with a connected insulin delivery device, please refer to the connected insulin delivery device user manual on how to locate the sensor serial number.)
    • If you are currently wearing or have a FreeStyle Libre 3 or FreeStyle Libre 3 Plus sensor that has been confirmed as potentially affected on FreeStyle Check or by a customer service representative, immediately discontinue use and dispose of the affected sensor(s).
    • You can request a replacement for any potentially affected sensor(s) on FreeStyle Check. Select “CONFIRM SENSOR SERIAL NUMBER” and enter a valid serial number. If your sensor is potentially impacted, you will be instructed to enter your contact information so a replacement product can be sent to you at no cost.
    • Use a blood glucose meter or the built-in meter in your FreeStyle Libre 3 Reader to make treatment decisions when your sensor readings don’t match your symptoms or expectations.

Visit the FDA’s website for additional information and instructions on how to locate the Sensor’s Serial Number.